← Leaderboards
Emer Leahy
Psychogenics, Inc.
$51,449,430
Attributed
$51,449,430
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $12.4M · FY2005–23$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$51,449,430 · 4
By mechanism
N01$49,781,254 · 1
R43$1,668,176 · 3
Top collaborators
No co-investigators on record.
Most similar at Psychogenics, Inc.
Same institution · by research overlap
- Paul McGonigle$1,350,000
- Barbara J. Caldarone$943,262
- Taleen G Hanania$1,607,051
- Taleen Hanania$21,254,211
- Afshin Ghavami$2,139,595
Others in their field
Top investigators on “Metabolic”
- David M Nathan · Massachusetts Institute Of Technology$157,845,616
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$144,157,234
- Judith S. Currier · University Of California Los Angeles$141,260,706
- John M Lachin · George Washington University$139,991,329
- Randall J Bateman · Washington University$124,168,384
- Carol Nesel · Westat$116,355,411
Research focus
MetabolicResponseUnited States National Institutes Of HealthTranslational ResearchPainClinical ResearchDevicesPre-ClinicalNational Institute Of Neurological Disorders And StrokeScreeningOpioidOpioid EpidemicBasic SciencePain ModelAddictionContractsNatural ProductsFosteringIn VivoIn VitroInvestigationBiologicalPain ManagementClinical Pain
Grant awards (12)
SCREENING OF INVESTIGATIONAL AGENTS THROUGH THE NINDS PRECLINICAL SCREENING PLATFORM FOR PAIN (PSPP)$9,216,959
N01 · FY2023 · DA · contact PI
SCREENING OF INVESTIGATIONAL AGENTS THROUGH THE NINDS PRECLINICAL SCREENING PLATFORM FOR PAIN (PSPP)$12,383,618
N01 · FY2022 · DA · contact PI
SCREENING OF INVESTIGATIONAL AGENTS THROUGH THE NINDS PRECLINICAL SCREENING PLATFORM FOR PAIN (PSPP)$10,891,025
N01 · FY2021 · DA · contact PI
SCREENING OF INVESTIGATIONAL AGENTS THROUGH THE NINDS PRECLINICAL SCREENING PLATFORM FOR PAIN (PSPP)$8,339,730
N01 · FY2020 · DA · contact PI
SCREENING OF INVESTIGATIONAL AGENTS THROUGH THE NINDS PRECLINICAL SCREENING PLATFORM FOR PAIN (PSPP)$5,825,160
N01 · FY2019 · DA · contact PI
PSPP - IDENTIFICATION AND VALIDATION OF NOVEL PAIN RELATED ENDPOINTS, NOVEL ANIMAL MODELS OF PAIN AND PROFILING OF INVESTIGATIONAL AGENTS IN RODENT AND NON-RODENT [EXCLUDING (NHP)] SPECIES$3,124,762
N01 · FY2019 · DA · contact PI
Eltoprazine for the Treatment of Cognitive Dysfunction Assoc. With Schizophrenia$350,000
R43 · FY2012 · MH · contact PI
Eltoprazine for the Treatment of Cognitive Dysfunction Assoc. With Schizophrenia$350,000
R43 · FY2011 · MH · contact PI
In Vivo Drug Discovery From Compound Mixtures$235,878
R43 · FY2006 · MH · contact PI
HIGH THROUGHPUT IN VIVO DRUG DISCOVERY-PHASE 1$250,000
R43 · FY2005 · MH
In Vivo Drug Discovery From Compound Mixtures$232,298
R43 · FY2005 · MH
HIGH THROUGHPUT IN VIVO DRUG DISCOVERY-PHASE 1$250,000
R43 · FY2004 · MH